In conclusion, the TyG–ALT index is associated with the severity of US-FLI, suggesting that it can be used as a simple, inexpensive, and useful tool to predict the severity of NAFLD in clinical practice without liver biopsy or ultrasonography. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.